Analystreport

Crescent Biopharma (NASDAQ:CBIO) was given a new $32.00 price target on by analysts at Stifel Nicolaus.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors